Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Withdrawn 1

Sponsor Class

OTHER 1NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Vipoma 1Uterine Cervical Dysplasia 1Squamous Intraepithelial Lesions 1Somatostatinoma 1Lymphoma, Non-Hodgkin 1Lymphoma, Large-Cell, Immunoblastic 1Lymphoma, Large-Cell, Anaplastic 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma, Follicular 1Lymphoma, AIDS-Related 1Leukemia, Myelomonocytic, Acute 1Leukemia, Myeloid, Acute 1Leukemia, Monocytic, Acute 1Leukemia, Megakaryoblastic, Acute 1Leukemia, Erythroblastic, Acute 1Insulinoma 1Glucagonoma 1Gastrinoma 1Congenital Abnormalities 1Carcinoma, Islet Cell 1Burkitt Lymphoma 1

Interventions

Cytarabine 14Daunorubicin 8Gemtuzumab 7Gene Expression Profiling 6Flow Cytometry 6sargramostim 5Filgrastim 5Mitoxantrone 4Idarubicin 4Etoposide 4Clofarabine 3Polymerase Chain Reaction 2Peripheral Blood Stem Cell Transplantation 2Observation 2Immunologic Techniques 2DNA Methylation 2Amplified Fragment Length Polymorphism Analysis 2zosuquidar trihydrochloride 1valspodar 1fludarabine phosphate 1etoposide phosphate 1Topotecan 1Thiotepa 1Reverse Transcriptase Polymerase Chain Reaction 1Radiotherapy 1Pharmacogenomic Testing 1Microarray Analysis 1Methotrexate 1Granulocyte Colony-Stimulating Factor 1Electrophoresis, Polyacrylamide Gel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Leukemia, Megakaryoblastic, Acute × Biological Therapy × Clear all
NCT00101140 2017-10-19

Donor Stem Cell Transplant in Treating Patients With Acute Myeloid Leukemia in Remission

Eastern Cooperative Oncology Group

Phase 2 Withdrawn
Other hematologic neoplasm

Congenital Abnormalities, Leukemia, Erythroblastic, Acute, Leukemia, Megakaryoblastic, Acute, Leukemia, Monocytic, Acute, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡